This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

AngioDynamics Inc.
ANGO : NASDAQ : Health Care

$14.24 -0.12 | -0.84%
Today's Range: 14.17 - 14.43
Avg. Daily Volume: 156,700
04/21/14 - 11:11 AM ET

Financial Analysis


ANGIODYNAMICS INC's gross profit margin for the third quarter of its fiscal year 2013 is essentially unchanged when compared to the same period a year ago. Sales and net income have grown, and although the growth in revenues has outpaced the average competitor within the industry, the net income growth has not. ANGIODYNAMICS INC has average liquidity. Currently, the Quick Ratio is 1.06 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.

At the same time, stockholders' equity ("net worth") has remained virtually unchanged only increasing by 1.95% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q3 FY13 Q3 FY12
Net Sales ($mil)88.281.57
EBITDA ($mil)12.9112.69
EBIT ($mil)6.436.28
Net Income ($mil)5.11-0.99


Balance Sheet Q3 FY13 Q3 FY12
Cash & Equiv. ($mil)9.1918.78
Total Assets ($mil)792.17796.47
Total Debt ($mil)138.91144.38
Equity ($mil)537.69527.36


Profitability Q3 FY13 Q3 FY12
Gross Profit Margin53.1652.78
EBITDA Margin14.6315.56
Operating Margin7.297.7
Sales Turnover0.440.39
Return on Assets0.46-0.85
Return on Equity0.69-1.28
Debt Q3 FY13 Q3 FY12
Current Ratio2.212.19
Debt/Capital0.210.21
Interest Expense0.921.27
Interest Coverage7.014.94


Share Data Q3 FY13 Q3 FY12
Shares outstanding (mil)35.2734.9
Div / share0.00.0
EPS0.14-0.03
Book value / share15.2415.11
Institutional Own % n/a n/a
Avg Daily Volume154274.0183621.0

Valuation


HOLD. ANGIODYNAMICS INC's P/E ratio indicates a significant premium compared to an average of 28.49 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 18.59. For additional comparison, its price-to-book ratio of 0.92 indicates a significant discount versus the S&P 500 average of 2.56 and a significant discount versus the industry average of 4.85. The price-to-sales ratio is below the S&P 500 average and is well below the industry average, indicating a discount.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ANGO 127.00 Peers 28.49   ANGO 18.49 Peers 29.42

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

ANGO is trading at a significant premium to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ANGO is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ANGO 31.04 Peers 18.86   ANGO NM Peers 0.92

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

ANGO is trading at a significant premium to its peers.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ANGO's negative PEG ratio makes this valuation measure meaningless.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ANGO 0.92 Peers 4.85   ANGO 142.30 Peers -2.90

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ANGO is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

ANGO is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ANGO 1.41 Peers 3.94   ANGO 13.15 Peers 5.82

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ANGO is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

ANGO has a sales growth rate that significantly exceeds its peers.

 

 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs